Fulgent Genetics awarded $99M contract by VA
The Fly

Fulgent Genetics awarded $99M contract by VA

Fulgent Genetics (FLGT) announced it has been awarded a five-year contract by the U.S. Department of Veterans Affairs, or VA, to provide hereditary cancer, pharmacogenetic and other genetic testing to Veterans. Fulgent has been periodically providing genetic testing services to the members of the VA since 2017. The award is for up to $99M over five years, including both hereditary cancer testing and pharmacogenetic testing.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App